These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6969207)

  • 1. alpha 1-Antitrypsin-levels and phenotypes in Crohn's disease in the Netherlands.
    Klasen EC; Biemond I; Weterman IT
    Gut; 1980 Oct; 21(10):840-2. PubMed ID: 6969207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity.
    Meyers S; Wolke A; Field SP; Feuer EJ; Johnson JW; Janowitz HD
    Gastroenterology; 1985 Jul; 89(1):13-8. PubMed ID: 3874110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease.
    Karbach U; Ewe K; Bodenstein H
    Gut; 1983 Aug; 24(8):718-23. PubMed ID: 6603392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Crohn's disease activity and alpha 1-antitrypsin in faeces.
    Arndt B; Schürmann G; Betzler M; Herfarth C; Schmidt-Gayk H
    Lancet; 1992 Oct; 340(8826):1037. PubMed ID: 1357424
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R
    Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha 1-antitrypsin in thalassemia major].
    Romeo MA; Milone G; Emma F; Li Volti S; Di Dio R; Musumeci S
    Pediatr Med Chir; 1983; 5(5):351-3. PubMed ID: 6336195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doppler sonography evaluation of superior mesenteric artery flow to assess Crohn's disease activity: correlation with clinical evaluation, Crohn's disease activity index, and alpha 1-antitrypsin clearance in feces.
    van Oostayen JA; Wasser MN; van Hogezand RA; Griffioen G; Biemond I; Lamers CB; de Roos A
    AJR Am J Roentgenol; 1997 Feb; 168(2):429-33. PubMed ID: 9016220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood protein concentrations--are they parameters of disease activity in Crohn's disease?].
    Meryn S; Lochs H; Bettelheim P; Sertl K; Mulak K
    Leber Magen Darm; 1985 Jul; 15(4):160-4. PubMed ID: 3877229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of alpha-1-antitrypsin and thrombocytes in the assessment of inflammatory activity in Crohn disease].
    Tromm A; Hüppe D; Straub H; Krieg M; May B
    Med Klin (Munich); 1992 Feb; 87(2):53-7. PubMed ID: 1542282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha 1-Antitrypsin and coeliac disease in spain.
    Klasen EC; Polanco I; Biemond I; Vazquez C; Peña AS
    Gut; 1980 Nov; 21(11):948-50. PubMed ID: 6969683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-antitrypsin serum concentration and phenotypes in ulcerative colitis.
    Biemond I; Selby WS; Jewell DP; Klasen EC
    Digestion; 1984; 29(2):124-8. PubMed ID: 6610589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of fecal alpha 1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease.
    Boirivant M; Pallone F; Ciaco A; Leoni M; Fais S; Torsoli A
    Dig Dis Sci; 1991 Mar; 36(3):347-52. PubMed ID: 1995272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin allotypes in Crohn's disease in the Netherlands.
    Biemond I; de Lange GG; Weterman IT; Pena AS
    Gut; 1987 May; 28(5):610-2. PubMed ID: 3596342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
    Wewers MD; Casolaro MA; Crystal RG
    Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative differences in faecal alpha-1-antitrypsin in patients with Crohn's disease.
    Colombel JF; Mizon C; Balduyck M; Cortot A
    Gut; 1989 Feb; 30(2):279-80. PubMed ID: 2784776
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple method for the measurement of different forms of alpha 1 proteinase inhibitor in the faeces of patients with Crohn's disease.
    el Yamani J; Soudan B; Mizon C; Colombel JF; Balduyck M; Cortot A; Mizon J
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():418-21. PubMed ID: 1642448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1-antitrypsin phenotypes and serum concentrations in duodenal ulcer patients in The Netherlands.
    Biemond I; Goedhard JG; Klasen EC; van den Boomgaard DM; Kreuning J; Peña AS; Lamers CB
    Digestion; 1988; 39(1):20-5. PubMed ID: 3260879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.